NATR

Business Context and Reporting Period

Company: Nature's Sunshine Products, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 1998
Business Overview: The Company manufactures and distributes natural health and nutritional products through a direct sales marketing program utilizing an independent sales force of Managers and Distributors.

Key Financial Metrics

Note: All dollar amounts in thousands, except per-share data.

Material Changes vs. Prior Period

• Revenue Growth: Sales revenue increased 11% to $75.3 million, driven by a 13% increase in the number of Managers and expanded consumer awareness. Domestic sales rose 11%, while international sales rose 10%.
• Profitability: Net income increased 21% to $4.9 million. Operating income rose 22.6% to $7.9 million.
• Expense Trends:
  • Cost of Goods Sold (COGS): Increased 12.3% in absolute terms; margin slightly compressed due to higher freight and duty costs in international operations.
  • Volume Incentives: Increased 12.1% to $35.2 million (46.8% of sales), attributed to sales leader development in Brazil, Mexico, and Venezuela.
  • SG&A Expenses: Increased 4.1% to $18.7 million but decreased as a percentage of sales due to improved cost controls.
• Segment Performance:
  • Domestic: Operating income increased to $6.0 million.
  • Asia Pacific: Reported an operating loss of $559,000 (vs. $17,000 loss prior year) primarily due to Japanese yen devaluation and startup losses in a new South Korea subsidiary.
• Liquidity: Cash and cash equivalents increased by $9.6 million, driven by strong operating cash flow and increased accrued liabilities.

Outlook, Risks, and Management Commentary

• Guidance & Outlook: Management expects COGS to decrease slightly as a percent of sales due to manufacturing efficiencies. SG&A is expected to decrease as a percent of sales for the remainder of 1998. Volume incentives are expected to remain relatively constant as a percent of sales.
• Strategic Actions:
  • Price Adjustments: Price increases are planned in the Asia Pacific market to offset currency devaluation.
  • Capital Expenditures: $1.5 million paid in Q1 for domestic manufacturing/warehouse expansion; completion expected in Q2 1998. Remaining $1.8 million to be funded by working capital.
  • Share Repurchase: Acquired $2.1 million (approx. 84,000 shares) of treasury stock under a 500,000 share buyback program. Approximately 416,000 shares remain available for repurchase.
• Risks & Contingencies:
  • Foreign Exchange: Devaluation of the Japanese yen negatively impacted Asia Pacific sales and operating income.
  • Liquidity Risk: While current liquidity is strong, a prolonged economic downturn or decrease in product demand could adversely affect long-term liquidity. The Company currently has no external credit facility.
  • Legal: The Company is a defendant in various incidental lawsuits; management believes these will not have a material effect on financial position.
  • Year 2000: Management does not anticipate material costs to achieve Year 2000 compliance.

Investor Verification Checklist

• Verify the impact of the Japanese yen devaluation on future Asia Pacific revenue and the effectiveness of planned price increases.
• Monitor the completion and cost overruns of the new domestic manufacturing facility scheduled for Q2 1998.
• Track the execution of the remaining 416,000 shares in the stock buyback program and its impact on EPS.
• Assess the sustainability of the 13% growth in the independent sales force (Managers) and the associated volume incentive costs.
• Review the performance of the new South Korea subsidiary to determine if startup losses will stabilize.